Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 5/20 | 0.46 |
| ▸ | GAA | P10253 | 4/20 | 0.41 |
| ▸ | AMY2A | P04746 | 4/20 | 0.41 |
| ▸ | MGAM | O43451 | 2/20 | 0.41 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | TYR | P14679 | 4/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.40 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5181432 | 0.91 | TYR (0.41) | LGALS8GAAAMY2AALDH1A1TYR | |
| SCHEMBL2237219 | 0.85 | LGALS8 (0.49) | LGALS8GAAAMY2AMGAMAMY1A | |
| SCHEMBL17767394 | 0.85 | LGALS8 (0.49) | LGALS8TYR | |
| SCHEMBL16328640 | 0.85 | MAPK1 (0.41) | LGALS8ALDH1A1MAPK1 | |
| SCHEMBL17767384 | 0.84 | LGALS3 (0.50) | LGALS8AMY1ATYRLGALS3LGALS4 | |
| SCHEMBL1816454 | 0.84 | LGALS8 (0.49) | LGALS8GAAAMY2AMGAMAMY1A | |
| SCHEMBL4751806 | 0.84 | MAPK1 (0.41) | LGALS8GAAAMY2AMGAMAMY1A | |
| SCHEMBL17767392 | 0.83 | LGALS8 (0.56) | LGALS8GAAAMY2AMGAMAMY1A | |
| SCHEMBL12502058 | 0.83 | LGALS8 (0.48) | LGALS8GAAAMY2AMGAMAMY1A | |
| SCHEMBL8468755 | 0.83 | LGALS8 (0.52) | LGALS8GAAAMY2AMGAMAMY1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117835831-A | Flavor modulating composition | 玉米产品开发公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-115501172-A | Gel formulations for topical drug delivery | 丹麦技术大学 | 2022-12-23 | — | — | CN | disclosed |
| CN-107249570-B | Gel formulations for topical drug delivery | 丹麦技术大学 | 2022-08-09 | — | — | CN | disclosed |
| US-20210386669-A1 | GEL FORMULATIONS FOR LOCAL DRUG RELEASE | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2021-12-16 | — | — | US | disclosed |
| US-11065201-B2 | Gel formulations for local drug release | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2021-07-20 | — | — | US | disclosed |
| US-20180325819-A1 | GEL FORMULATIONS FOR LOCAL DRUG RELEASE | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2018-11-15 | — | — | US | disclosed |
| CN-107249570-A | Gel formulations for topical drug delivery | 丹麦技术大学 | 2017-10-13 | — | — | CN | disclosed |
| EP-3220887-A1 | GEL FORMULATIONS FOR LOCAL DRUG RELEASE | Technical University of Denmark (DK) | 2017-09-27 | — | — | EP | disclosed |
| WO-2016079331-A1 | GEL FORMULATIONS FOR ENHANCING THE EFFECT OF RADIOTHERAPY | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2016-05-26 | — | — | WO | disclosed |
| WO-2016079332-A1 | GEL FORMULATIONS FOR IMPROVING IMMUNOTHERAPY | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2016-05-26 | — | — | WO | disclosed |
| WO-2016079330-A1 | GEL FORMULATIONS FOR LOCAL DRUG RELEASE | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2016-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11065201-B2 | Gel formulations for local drug release | TREH, GALE, SLC2A8 | LGALS8 19/4885GAA 174/4885AMY2A 364/4885 |
| US-20180325819-A1 | GEL FORMULATIONS FOR LOCAL DRUG RELEASE | TREH, GALE, SLC2A8 | LGALS8 19/4885GAA 174/4885AMY2A 364/4885 |
| US-20210386669-A1 | GEL FORMULATIONS FOR LOCAL DRUG RELEASE | TREH, GALE, SLC2A8 | LGALS8 19/4885GAA 174/4885AMY2A 364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.